¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"point of proximal contact"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • contact stomatitis
    Á¢ÃËÀԾȿ°, Á¢Ã˱¸³»¿°
  • contact ulcer
    Á¢Ã˱˾ç
  • contact urticaria
    Á¢Ã˵ε巯±â
  • extended-wear contact lens
    ¿¬¼ÓÂø¿ëÄÜÅÃÆ®·»Áî, ¿¬¼ÓÂø¿ëÁ¢ÃË·»Áî
  • heel contact
    µÚÃàµó±â
  • hard contact lens
    ÇϵåÄÜÅÃÆ®·»Áî, °æ¼ºÄÜÅÃÆ®·»Áî
  • hydrophilic contact lens
    Ä£¼öÄÜÅÃÆ®·»Áî
  • irritant contact dermatitis
    ÀÚ±ØÁ¢ÃËÇǺο°
  • immediate contact
    Áï½ÃÁ¢ÃË
  • indirect contact
    °£Á¢Á¢ÃË
  • intercellular contact
    ¼¼Æ÷»çÀÌÁ¢ÃË, ¼¼Æ÷°£Á¢ÃË
  • intercellular contact layer
    ¼¼Æ÷»çÀÌÁ¢ÃËÃþ, ¼¼Æ÷°£Á¢ÃËÁõ
  • photoallergic contact dermatitis
    ±¤¾Ë·¹¸£±âÁ¢ÃËÇǺο°
  • primary contact
    ÀÏÂ÷Á¢ÃË
  • soft contact lens
    ¼ÒÇÁÆ®ÄÜÅÃÆ®·»Áî, ¿¬¼ºÄÜÅÃÆ®·»Áî
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • contact scrotal thermography
    À½³¶Á¢Ã˿µµÃøÁ¤¼ú
  • heel contact
    µÚÃàµó±â
  • immediate contact
    Áï½ÃÁ¢ÃË
  • indirect contact
    °£Á¢Á¢ÃË
  • intercellular contact
    ¼¼Æ÷»çÀÌÁ¢ÃËÃþ
  • primary contact
    ÀÏÂ÷Á¢ÃË
  • secondary contact
    ÀÌÂ÷Á¢ÃË
  • photoallergic contact dermatitis
    ±¤¾Ë·¹¸£±âÁ¢ÃËÇǺο°
  • extended-wear contact lens
    ¿¬¼ÓÂø¿ëÄÜÅÃÆ®·»Áî, ¿¬¼ÓÂø¿ëÁ¢ÃË·»Áî
  • hard contact lens
    ÇϵåÄÜÅÃÆ®·»Áî
  • hydrophilic contact lens
    Ä£¼öÄÜÅÃÆ®·»Áî
  • intercellular contact layer
    ¼¼Æ÷°£Á¢ÃËÃþ
  • scleral contact lens
    °ø¸·ÄÜÅÃÆ®·»Áî
  • soft contact lens
    ¼ÒÇÁÆ®ÄÜÅÃÆ®·»Áî
  • therapeutic contact lens
    Ä¡·áÄÜÅÃÆ®·»Áî
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • NPA->near point of accommodation
    Á¶Àý±ÙÁ¡
  • NPC->near point of convergence
    ´«¸ðÀ½±ÙÁ¡, ÆøÁÖ±ÙÁ¡
  • Wilkerson point system
    ÀªÄ¿½¼Á¡¼öü°è
  • alveolar point =prosthion
    Ä¡Á¶Á¡(¡­ïÇ).
  • apex beat =point of maximum impulse
    ½É÷¹Úµ¿(ãýôÓÚÑÔÑ)
  • freezing point
    ¾î´ÂÁ¡(¡­ïÇ), ºù°áÁ¡(޼̿ïÇ), ÀÀ°íÁ¡(ëêͳïÇ).
  • freezing point depression
    ¾î´ÂÁ¡°­ÇÏ(¡­Ë½ù»).
  • freezing point depression
    ¾î´ÂÁ¡°­ÇÏ
  • gingival point angle
    Ä¡°æÃ·°¢(öÍ ôÓÊÇ).
  • gluteal point
    µÐ Á¡.
  • gold point
    ±ÝÀÀ°íÁ¡(ÐÝëêͳïÇ).
  • halting point
    Á¤ÁöÁ¡(ïÎò­ïÇ).
  • heat rigor point
    ¿­°æÁ÷Á¡(¡­ïÇ).
  • heat rigor point
    ¿­°æÁ÷Á¡(ÊÙËø).
  • ice point
    ºùÁ¡(Ë×Ëø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • proximal tubule
    ±ÙÀ§¿ä¼¼°ü(ÐÎêÈèñá¬Î·).
  • proximal vitelline part
    ¸öÂʳ­È²ºÎºÐ
  • proximal vitelline sac
    ¸öÂʳ­È²ÁÖ¸Ó´Ï
  • proximal ³ª proximalis
    ±ÙÀ§, ±ÙÀ§(ÐÎêÈ)ÀÇ.
  • proximal ³ª proximalis
    ±ÙÀ§, ±ÙÀ§(ÐÎêÈ)ÀÇ.
  • affective contact
    Á¤µ¿Àû Á¢ÃË(¡­ïÈõº).
  • allergic contact dermatitis
    ¾Ë·¹¸£±â Á¢ÃËÇǺο°( ïÈõºù«Ý±æú)
  • allergy, contact
    Á¢Ã˼º ¾Ë·¹¸£±â
  • arc of contact
    Á¢Ã˸é, Á¢ÃËÆø
  • bifocal contact lens
    ÀÌÁßÃÊÁ¡ÄÜÅÃÆ®·»Áî
  • cell,contact inhibition
    Á¢Ã˾ïÁ¦ (ïÈõºåäð¤)
  • contact
    Á¢ÃË(ïÈõº).
  • contact
    Á¢ÃË(ïÈõº)
  • contact (gunshot) wounds
    Á¢»çÃÑâ
  • contact allergy
    Á¢Ã˼º ¾Ë·¹¸£±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • melting point
    À¶ÇØÁ¡(ë×ú°ïÆ)
  • point mutation
    Á¡º¯ÀÌ(ïÃܨì¶)
  • point quenching
    Á¡¼ÒÆÎ(ïÃá¼ÎÃ)
  • point symmetry
    Á¡´ëĪ(ïÃÓßöà)
  • restriction point
    Á¦ÇÑÁ¡(ð¤ùÚïÃ)
  • R point
    (å²) Restriction point
  • thermal death point
    ¿­»çÁ¡(æðÞÝïÃ)
  • thermal inactivation point
    ¿­ºÒȰ¼ºÈ­Á¡ (æðÝÕüÀàõûùïÃ)
  • three-point attachment
    ¼¼°÷ ºÎÂø(Üõó·)
  • three-point cross
    ¼¼Á¡ ±³Â÷(Îßó©)
  • three-point landing
    ¼¼°÷ ¾É±â
  • two-point cross
    ÀÌÁ¡±³Â÷(ì£ïÇÎßó©)
  • zero point
    ¿µÁ¡(ÖÃïÇ)
  • zero-point mutation
    ¿µÁ¡(ÖÃïÇ) º¯ÀÌ(ܨì¶)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
Si the most anterior point on the lower contour of the sella turcica [point]; silicon
TP temperature and pressure; temperature probe; temporal peak; temporoparietal; tension pneumothorax; t...
ACD   1) Absolute Cardiac Dullness; Àý´ë½ÉµÐŹÀ½
  2) Anemia of Chronic Disease
&nbs...
SCMCT Sperm Cervical Mucus Contact Test
ACD absolute cardiac dullness; absolute claudication distance; acid-citrate-dextrose [solution]; actinom...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CMR contact micro radiography
CPS contact photosensitivity
CCP critical control point
CPD Critical point drying
GPA Grade Point Average
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • contact time
    Á¢ÃË ½Ã°£
  • damaging contact
    À§ÇØ Á¢ÃË
  • final centric relation occlusal contact
    ÃÖÁ¾ Áß½ÉÀ§ ±³ÇÕ Á¢ÃË
  • heavy posterior contact
    ±¸Ä¡ºÎ °ú´Ù Á¢ÃË
    ±³ÇÕ ÀÌ»óÀ¸·Î ÀÎÇÑ ±¸Ä¡ºÎ °ú´Ù Á¢ÃËÀº ÅΰüÀý Àå¾Ö, ¶Ç Ä¡¾ÆÀÇ ½ÉÇÑ ¸¶¸ð°¡ ÀϾ ¼ö ÀÖ´Ù.
  • hydrogel contact lens
    ÇÔ¼ö ÄÜÅÃÆ® ·»Áî
  • immediate contact
    Á÷Á¢ Àü¿°
    Àü¿°¼º ÁúȯÀ» °¡Áø »ç¶÷¿¡°Ô °Ç°­ÇÑ »ç¶÷ÀÌ Á¢ÃËÇÏ¿© ±× °á°ú·Î¼­ º´ÀÌ ¿Å°ÜÁö´Â °Í.
  • initial contact
    ¿¹ºñ Á¢ÃË, Ãʱâ Á¢ÃË
    1. ÇϾÇÀÌ »ó¾ÇÀ» ÇâÇØ ¿Ã¶ó¿À¸é¼­ ´ëÇÕÄ¡°£¿¡ Á¦ÀÏ ¸ÕÀú ÀϾ´Â Á¢ÃË. Æó±¸ÇÒ ¶§ »óÇÏ¾Ç Ä¡¾Æ°£¿¡ ÀϾ´Â Á¢ÃËÀº ºñÁ¤»óÀûÀ̰ųª °£¼·ÀûÀÎ °ÍÀº ¾Æ´Ï´Ù. 2. ÅÎÀ» ´Ù¹°¾úÀ» ¶§ ÃÖÃÊ¿¡ ÀϾ´Â »ó¾Ç Ä¡¾Æ¿Í ÇÏ¾Ç Ä¡¾Æ¿ÍÀÇ Á¢ÃË.
  • initial occlusal contact
    Ãʱ⠱³ÇÕ Á¢ÃË
  • intercuspal contact
    ±³µÎ°£ Á¢ÃË
  • intercuspal contact position
    ±³µÎ°£ Á¢ÃËÀ§
  • interproximal contact
    ÀÎÁ¢¸é Á¢ÃË
  • laterotrusive contact
    ¿ÜÃø¹æ Á¢ÃË
  • maximum intercuspal contact
    ÃÖ´ë ±³ÇÕ Á¢ÃË
  • non-working occlusal contact
    ºñÀÛ¾÷Ãø ±³ÇÕ Á¢ÃË
  • nonworking posterior contact
    ºñÀÛ¾÷Ãø ÈĹæ Á¢ÃË
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
contact induced spreading The response in which contact between two epithelial cells leads to a stabilised contact and the increased spreading of the cells so that the area covered is greater than that covered by the two cells in isolation.
(18 Nov 1997)
contact inhibition The inhibition of continued growth and division of a cell or colony due to physical contact with other cells or colonies. The stopping of continued growth when a certain density of cells has been reached.
The momentary stopping of all movement when a mobile cell runs into another cell.
(09 Oct 1997)
contact inhibition of growth See: density dependent inhibition.
(18 Nov 1997)
contact inhibition of movement Reaction in which the direction of motion of a cell is altered following collision with another cell. In heterologous contacts both cell may respond (mutual inhibition) or only one (nonreciprocal). Type I contact inhibition involves paralysis of the locomotory machinery, Type II is a consequence of adhesive preference for the substratum rather than the dorsal surface of the other cell.
(18 Nov 1997)
contact inhibition of phagocytosis Phenomenon described in sheets of kidney epithelial cells that, when confluent, lose their weak phagocytic activity, probably because of a failure of adhesion of particles to the dorsal surface in the absence of ruffles.
(18 Nov 1997)
contact lens A lens that fits over the cornea and sclera or cornea only; used to correct refractive errors.
(05 Mar 2000)
contact lenses Curved shells of glass or plastic applied directly over the globe or cornea to correct refractive errors.
(12 Dec 1998)
contact lenses, extended-wear Hydrophilic contact lenses worn for an extended period or permanently.
(12 Dec 1998)
contact lenses, hydrophilic Soft, supple contact lenses made of plastic polymers which interact readily with water molecules. Many types are available, including continuous and extended-wear versions, which are gas-permeable and easily sterilised.
(12 Dec 1998)
contact lens solutions Sterile solutions used to clean and disinfect contact lenses.
(12 Dec 1998)
contact rate <epidemiology> The rate at which susceptibles meet infecteds. Usually measured as individuals per unit time.
(05 Dec 1998)
contact sensitivity Allergic response to contact with irritant, usually a hypersensitivity.
(18 Nov 1997)
contact sites A Developmentally regulated adhesion sites that appear on the ends of aggregation competent Dictyostelium discoideum at the stage when the starved cells begin to come together to form the grex. Originally detected by the use of Fab fragments of polyclonal antibodies, raised against aggregation competent cells and adsorbed against vegetative cells, to block adhesion in EDTA containing medium. (Cell cell adhesion mediated by contact sites A, unlike that mediated by contact sites B, is not divalent cation sensitive). The fact that a mutant deficient in csA behaves perfectly normally in culture is puzzling.
(18 Nov 1997)
contact sites B Developmentally regulated adhesion sites that appear on the ends of aggregation competent Dictyostelium discoideum at the stage when the starved cells begin to come together to form the grex. Originally detected by the use of Fab fragments of polyclonal antibodies, raised against aggregation competent cells and adsorbed against vegetative cells, to block adhesion in EDTA containing medium. (Cell cell adhesion mediated by contact sites A, unlike that mediated by contact sites B, is not divalent cation sensitive). The fact that a mutant deficient in csA behaves perfectly normally in culture is puzzling.
(18 Nov 1997)
contact splint A slotted plate, held by screws, used in the treatment of fracture of long bones.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • black point
    Èæ¼öº´
  • boiling point
    ºñµîÁ¡
  • bradkeven point
    ä»êÁ¡
  • burning point
    ¹ßÈ­Á¡
  • cover point
    ÈÄÀ§
  • critical point
    ÀÓ°èÁ¡
  • dead point
    =DEAD CENTER
  • decimal point
    ¼Ò¼öÁ¡
  • dew point
    (±â»ó)(¿ÂµµÀÇ)À̽½Á¡;³ëÁ¡
  • dropoff point
    ¹è´Þǰ Àü´Þ Àå¼Ò;(À¯±« »ç°Ç µî¿¡¼­)¸ö°ªÀ» µÎ°í °¡´Â Àå¼Ò
  • end point
    Á¾·áÁ¡;Á¾Á¡;(È­)(ÀûÁ¤ÀÇ)Á¾Á¡;=ENDPOINT
  • equinoctial point
    (õ)ºÐÁ¡;ÁÖ¾ß ÆòºÐÁ¡
  • equitime point
    ÇൿÇѰèÁ¡;ÁøÃâ ÇѰèÁ¡
  • etching needle (point)
    ¿¡Äª¿ë Á¶°¢Ä§
  • far point
    ¿øÁ¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á